COMP <GO>
THC vs UNH // NET PROFIT MARGIN
Tenet Healthcare Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: THC 8
— UNH 7
▲ NET PROFIT MARGIN LEADER: THC
LAST: $273.25 (+0.99%) • MKT CAP: $21.79B
net-margins
11.10%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
net-margins
3.14%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (THC VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | THC | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 27.60% | 11.47% | +16.13 | THC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.3x | 16.4x | -10.15 | THC | /valuation <GO> |
| Free Cash Flow Yield | 11.61% | 6.48% | +5.13 | THC | /fcf-yield <GO> |
| Operating Margin | 16.50% | 4.82% | +11.68 | THC | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 11.10% | 3.14% | +7.96 | THC | /net-margins <GO> |
| Revenue Growth (YoY) | 3.10% | 6.46% | -3.36 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.08 | 3.12 | -1.04 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.74% | +0.06 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.2 | 56.0 | +2.11 | THC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 0.33 | +0.64 | THC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 17.1x | -8.49 | THC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.79B | $364.66B | -$342.87B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | THC REV | UNH REV | THC GROSS % | UNH GROSS % | THC FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.31B | $447.57B | 44.0% | 88.7% | $2.53B | $16.07B |
| FY 2024 | $20.68B | $400.28B | 44.0% | 88.3% | $1.12B | $20.70B |
| FY 2023 | $20.56B | $371.62B | 44.0% | 89.6% | $1.45B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
THC // BETA 0.97
UNH // BETA 0.33